CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics - ScienceDirect

Implementing genome-driven personalized cardiology in clinical practice - Journal of Molecular and Cellular Cardiology

Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness - Cytotherapy

PDF) Human and Mouse Artificial Chromosome Technologies for Studies of Pharmacokinetics and Toxicokinetics

Mitochondrial medicine in the omics era - The Lancet

Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the DMPK gene: Molecular Therapy - Nucleic Acids

Evaluation of Hepatic Uptake of OATP1B Substrates by Short Term-Cultured Plated Human Hepatocytes: Comparison With Isolated Suspended Hepatocytes - Journal of Pharmaceutical Sciences

PDF) Genome editing and cancer: How far has research moved forward on CRISPR /Cas9?

PDF) Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine

Localized immunomodulation technologies to enable cellular and organoid transplantation: Trends in Molecular Medicine

Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury - Journal of Pharmaceutical Sciences

CRISPR-Cas9 system: A genome-editing tool with endless possibilities - ScienceDirect

Chemical Biology and its relations to Metabolic Disease, Leaders in Pharmaceutical Business Intelligence (LPBI) Group

CRISPR-Cas9 correction in the DMD mouse model is accompanied by upregulation of Dp71f protein: Molecular Therapy - Methods & Clinical Development

Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome - ScienceDirect